тел. +38 (044) 483-12-82

№3-4(8) 2025

Укр

DOI 10.37219/2528-8253-2025-3-4-72

Kishchuk VV, Isnyuk AS, Bartsikhovskiy AI, Dmitrenko ІV, Bondarchuk OD, Lobko KA, Gritsun YaP
CURRENT ISSUES OF DIAGNOSIS AND TREATMENT OF SCLEROMA (BIBLIOGRAPHICAL REVIEW, OWN EXPERIENCE)
Kishchuk Vasyl V
National Pirogov Memorial Medical University, Vinnytsya, Ukraine
Department of Otolaryngology, Head of Department
Doctor of Medical Sciences, Professor
Email: kvv4488@ukr.net
ORCHID ID: http://orcid.org/0000-0002-3390-2401
Scopus Author ID: 8093682700
ResearcherID: V-2242-2018
Bartsikhovsky Andrey I
National Pirogov Memorial Medical University, Vinnytsya, Ukraine
Department of Otolaryngology
PhD, Associate Professor
Email: ABartsikhovskiy@ukr.net
ORCHID ID: http://orcid.org/0000-0002-5809-2978
Scopus Author ID: 6504757449
Scopus Author ID: 57204652553
Bondarchuk Oleksandr D.
Mykola Pyrohov Vinnytsia Regional Hospital, Vinnytsia, Ukraine
Department of Otolaryngology
PhD
Mykola Pyrohov Vinnytsia Regional Hospital
E-mail: eskulap20009@gmail.com
ORCID ID: https://orcid.org/0000-0002-7636-9694
Dmitrenko Igor V.
National Pirogov Memorial Medical University, Vinnytsya, Ukraine
Department of Otolaryngology
Mykola Pyrohov Vinnytsia Regional Hospital
PhD
Email: Igor.dmitrenko72@gmail.com
Orchid ID: http://orcid.org/0000-0002-4535-588X
Isnyuk Andriy S
National Pirogov Memorial Medical University, Vinnytsya, Ukraine
Department of Otolaryngology
Assistant of the Department
Mykola Pyrohov Vinnytsia Regional Hospital
Email: dr.a.isniuk@gmail.com
ORCHID ID: http://orcid.org/0000-0002-6649-7748
Scopus Author ID: 57204650296
Lobko Katerina A.
National Pirogov Memorial Medical University, Vinnytsya, Ukraine
Department of Otolaryngology
Associate Professor
Mykola Pyrohov Vinnytsia Regional Hospital, Vinnytsia, Ukraine
PhD
E-mail: Katvin19@ukr.net
ORCID ID: https://orcid.org/0000-0002-0045-2352
Hrytsun Yaroslav P.
National Pirogov Memorial Medical University, Vinnytsya, Ukraine
Department of Otolaryngology
Associate Professor
PhD (Med) Docent
Mykola Pyrohov Vinnytsia Regional Hospital, Vinnytsia, Ukraine
E-mail: gtitsunjp86@gmail.com
ORCID ID: https://orcid.org/0000-0002-3541-3636

Abstract

The paper presents an analysis of literature data and own observations of the scleroma pathogenetic treatment problem, which remains relevant and not fully resolved. However, the achievements of modern molecular microbiology in the near future can really change the algorithm of management of treatment of patients with scleroma due to early diagnosis.

The paper discusses the principles of etiopathogenetic treatment of patients with scleroma in the “Republican Scleroma Center”, which has been operating since 1980 on the basis of the ENT clinic of the Vinnytsia Regional Clinical Hospital named after M.I. Pirogov by order No. 282 of the Ministry of Health of the Ukrainian SSR dated April 29, 1980. The principles of treatment of scleroma depend on the clinical form (mainly cicatricial, infiltrative, atrophic), the characteristics of airway stenosis (localization, histological stage, degree), the availability and effectiveness of its pharmacotherapy.

Keywords: scleroma, rhinoscleroma, Klebsiella rhinoscleromatis, infiltrates, airway stenosis, scleroma treatment, dilation, bouging, stenting, tracheostomy, antibiotic therapy, probiotic lactobacilli medicines.

Download.PDF

References

  1. Baryliak RA. [Geography of the East European scleroma focus]. In: Actual Problems of Scleroma. Kyiv; 1967. p. 6-8. [In Ukrainian].
  2. Baryliak RA, Sakhelashvili NA, Evdoschenko EA. [Scleroma]. Kyiv: Zdorovya; 1974. 184 p. [In Russian].
  3. Bartsykhovskyi AI, Kishchuk VV, Shetmanyuk HV, Zavadskyi YeD, Bartsykhovskyi KA, Lobko KA. Distribution of scleroma in Central and South American countries. Bibliographic review. In: Materials of the Annual Traditional Spring Conference of the Ukrainian Scientific Medical Society of Otorhinolaryngologists “New Technologies in Otorhinolaryngology”; Kyiv; 2012. p. 24. Available from: https://dspace.vnmu.edu.ua/handle/123456789/1204. [Article in Ukrainian].
  4. Bielenichev IF, Kucherenko LI, Mazur IA. [Diagnostics of scleroma]. Exper Physiol Biochem. 2002;(12):24-9. [Article in Ukrainian].
  5. Velychko VM. Blood antigens, somatotype and dermatoglyphics in patients with scleroma and possibilities of its prognosis [dissertation]. Kyiv; 1990. 25 p. [In Russian].
  6. Viktorov IV. [Treatment of scleroma]. Vestn. RAMN. 2005;(4):5-9. [Article in Russian].
  7. Habrylovych IM, Stefanov SB. [Structural organization of scleroma bacteriophages]. In: Actual Problems of Scleroma. Kyiv; 1967. p. 49-50. [Article in Ukrainian].
  8. Hudivok YaS, Holubeva MH. [Treatment of patients with scleroma]. Liky Ukrainy. 2005;(Suppl):41. [Article in Ukrainian].
  9. Dal MK, Zarytskyi LA, Kolomiychenko AI. [Scleroma]. Kyiv: Gosmedizdat URSR; 1959. p. 15661. [In Russian].
  10. Derepa VK. [Complex treatment of patients with scleroma using local levamisole] [dissertation]. Kyiv; 1987. 28 p. [In Russian].
  11. Derepa KP. [Some aspects of scleroma pathogenesis and pathogenetic therapy: experimental and clinical observations, laboratory and histochemical studies] [dissertation]. Kyiv: Kyiv Medical Institute named after O.O. Bohomolets; 1966. 39 p. [In Russian].
  12. Dmytrenko IV. [Complex pathogenetic treatment of patients with scleroma using radon water and thiotriazoline] [dissertation]. Kyiv: SI “O.S. Kolomiychenko Institute of Otolaryngology NAMS of Ukraine”; 2009. 34 p. Available from: https://dspace.vnmu.edu.ua/handle/123456789/3572. [In Ukrainian].
  13. Zarytskyi LA. [Scleroma of the respiratory tract]. Kyiv: Gosmedizdat URSR; 1948. 103 p. [In Russian].
  14. Kitsera O. [Clinical Otorhinolaryngology]. Lviv; 2006. 531 p. [In Ukrainian].
  15. Kishchuk VV, Hrytsun YaP, Dmytrenko IV, Bondarchuk OD, Lobko KA, Bartsykhovskyi AI. [Our experience in the use of inhaled fluticasone propionate in complex treatment of scleroma]. Zhurnal ushnyh, nosovyh i gorlovyh boleznej. 2016;(5-с):61-2. Available from: https://dspace.vnmu.edu.ua/handle/123456789/10118. [Article in Ukrainian].
  16. Kishchuk VV, Dmytrenko IV, Bartsykhovskyi AI, Bondarchuk OD, Lobko KA, Hrytsun YaP. [Use of copper sulfate in complex pathogenetic treatment of patients with scleroma]. Zhurnal ushnyh, nosovyh i gorlovyh boleznej. 2016;(5-с):60-1. Available from: https://dspace.vnmu.edu.ua/handle/123456789/9771. [Article in Ukrainian].
  17. Kishchuk VV, Isniuk AS, Bondarchuk OD, Lobko KA, Dmytrenko IV, Bartsykhovskyi AI, et al. [Features of nasal and oropharyngeal microbiocenosis in patients with scleroma]. Zhurnal ushnyh, nosovyh i gorlovyh boleznej. 2017;(3-с):51. Available from: https://dspace.vnmu.edu.ua/handle/123456789/1235. [Article in Ukrainian].
  18. Kishchuk VV, Bartsykhovskyi AI, Dmytrenko IV, Bondarchuk OD, Lobko KA, Isniuk AS, et al. [Dynamics of scleroma prevalence in Ukraine according to the Ukrainian Scleroma Center (2001-2016)]. In: Materials of the Annual Traditional Spring Conference of the Ukrainian Scientific Medical Society of Otorhinolaryngologists “Achievements of Modern Otolaryngology”; Kyiv; 2017. p. 47-8. Available from: https://dspace.vnmu.edu.ua/handle/123456789/1174. [Article in Ukrainian].
  19. Kishchuk VV, Hrytsun YaP, Dmytrenko IV, Bartsykhovskyi AI, Bondarchuk AD, Lobko KA, et al. [Systemic humoral immunity status in patients with scleroma]. Otorhinolaryngol East Eur. 2018;8(1):43-8. Available from: https://dspace.vnmu.edu.ua/handle/123456789/2920. [Article in Russian].
  20. Kishchuk VV, Dmytrenko IV, Bondarchuk AD, Lobko KA, Hrytsun YaP, Isniuk AS, Bartsykhovskyi AI. [Scleroma: clinical forms and treatment tactics]. Otorhinolaryngol East Eur. 2018;8(1):98-104. Available from: https://dspace.vnmu.edu.ua/handle/123456789/2919. [Article in Russian].
  21. Leschuk-Rachkevych IP. [Influence of bacteriophage on the sensitivity of scleroma bacteria to antibiotics]. In: Actual Problems of Scleroma. Kyiv; 1967. p. 61-6. [Article in Ukrainian].
  22. Kraizman ShN. [Experience of scleroma patient dispensary observation in Volyn region]. In: Actual Problems of Scleroma. Kyiv; 1967. p. 19-21. [Article in Ukrainian].
  23. Plaksivyi OH, Kalutskyi IV, Mazur OO, Kurulyak NH, Rusnak AI. [Scleroma of the upper respiratory tract with chronic tracheal stenosis and severe respiratory failure in an elderly woman]. Zhurnal ushnyh, nosovyh i gorlovyh boleznej. 2016;(4):73-5. Available from: https://archive.iol.com.ua/2016/2016_4_63.pdf. [Article in Ukrainian].
  24. Penkovyi VI. [Complex treatment of patients with scleroma using vaccinotherapy and propolis preparations] [dissertation]. Kyiv; 1980. 24 p. [In Russian].
  25. Petretskyi VV, Petrus VS. [Scleroma in Zakarpattia region]. In: Actual Problems of Scleroma. Kyiv; 1967. p. 18-9. [Article in Ukrainian].
  26. Sakhelashvili NA. [Antibiotics and other chemotherapeutic agents in the treatment of scleroma]. In: Actual Problems of Scleroma. Kyiv; 1967. p. 122-6. [Article in Ukrainian].
  27. Abalkhail A, Satti MB, Uthman MA, Al Hilli F, Darwish A, Satir A. Rhinoscleroma: a clinicopathological study from the Gulf region. Singapore Med J. 2007 Feb;48(2):148-51. Available from: https://www.sma.org.sg/smj/4802/4802a7.pdf.
  28. Amoils CP, Shindo ML. Laryngotracheal manifestations of rhinoscleroma. Ann Otol Rhinol Laryngol. 1996 May;105(5):336-40. doi: 10.1177/000348949610500502.
  29. Basak S, Singh P, Rajurkar M. Multidrug Resistant and Extensively Drug Resistant Bacteria: A Study. J Pathog. 2016;2016:4065603. doi: 10.1155/2016/4065603.
  30. Ben Gamra O, Zribi S, Hriga I, Chiraz, Mbarek, El Khedim A. [Rhinoscleroma]. Tunis Med. 2006 Dec;84(12):833-6. [Article in French].
  31. Chan TV, Spegel JH. Klebsiella rhinoscleromatis of the membranous nasal septum. J Laryngol Otol. 2007 Oct;121(10):998-1002. doi: 10.1017/S0022215107006421.
  32. De Pontual L, Ovetchkine P, Rodriguez D, Grant A, Puel A, Bustamante J, et al. Rhinoscleroma: a French national retrospective study of epidemiological and clinical features. Clin Infect Dis. 2008 Dec 1;47(11):1396-402. doi: 10.1086/592966.
  33. Fawaz S, Tiba M, Salman M, Othman H. Clinical, radiological and pathological study of 88 cases of typical and complicated scleroma. Clin Respir J. 2011 Apr;5(2):112-21. doi: 10.1111/j.1752-699X.2010.00207.x.
  34. Fevre C, Almeida AS, Taront S, Pedron T, Huerre M, Prevost MC, et al. A novel murine model of rhinoscleroma identifies Mikulicz cells, the disease signature, as IL-10 dependent derivatives of inflammatory monocytes. EMBO Mol Med. 2013 Apr;5(4):516-30. doi: 10.1002/emmm.201202023.
  35. Fevre C, Passet V, Deletoile A, Barbe V, Frangeul L, Almeida AS, et al. PCR-based identification of Klebsiella pneumoniae subsp. rhinoscleromatis, the agent of rhinoscleroma. PLoS Negl Trop Dis. 2011 May;5(5):e1052. doi: 10.1371/journal.pntd.0001052.
  36. Fusconi M, Greco A, Cattaneo CG, Ciofalo A, Ralli M, de Vincentiis M. Social geography of Rhinoscleroma and qualitatively and quantitatively abnormal cell-mediated immunity. Infect Genet Evol. 2018 Aug;62:17-9. doi: 10.1016/j.meegid.2018.03.018.
  37. Gupta A, Gupta V, Agarwal SR, Jain AK. A clinical study of local acriflavin in treatment of rhinoscleroma. Indian J Otolaryngol Head Neck Surg. 1999 Jan;51(1):51-4. doi: 10.1007/BF02996846.
  38. Herrak L, Maslout A, Benosmane A. [Tracheal scleroma and rhinoscleroma: a case report]. Rev Pneumol Clin. 2007 Apr;63(2):115-8. doi: 10.1016/s0761-8417(07)90112-1. [Article in French].
  39. Hotez PJ, Kamath A. Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis. 2009 Aug 25;3(8):e412. doi: 10.1371/journal.pntd.0000412.
  40. Keita M, Kampo MI, Timbo S, Traoré C, Diallo M, Doumbia-Singaru K, et al. [Morbidity of the tumours of the sphere head and neck in Bamako]. Mali Med. 2009;24(3):1-6. [Article in French].
  41. Muñoz-Saavedra D, Olavarría-Leiva C. [Laryngeal stenosis as late manifestation of rhinoscleroma. Case report]. Acta Otorrinolaringol Esp. 2010 May-Jun;61(3):241-3. doi: 10.1016/j.otorri.2009.10.005. [Article in Spanish].
  42. Pai S, Bhat VS, Adersh S. Rhinoscleroma – A Clinical Study and Review of Literature. Int J Health Sci Res. 2015;5(1):59-67. Available from: https://www.ijhsr.org/IJHSR_Vol.5_Issue.1_Jan2015/9.pdf
  43. Sánchez-Marín LA, Bross-Soriano D, Arrieta J, Kawa-Karasik S, Martínez-Vilchis V, Jiménez-Lucio R, et al. Association of HLA-DQA1*03011-DQB1*0301 haplotype with the development of respiratory scleroma. Otolaryngol Head Neck Surg. 2007 Mar;136(3):481-3. doi: 10.1016/j.otohns.2006.08.032.
  44. Simons ME, Granato L, Oliveira RC, Alcantara MP. Rhinoscleroma: case report. Braz J Otorhinolaryngol. 2006 Jul-Aug;72(4):568-71. doi: 10.1016/s1808-8694(15)31006-5.
  45. Szyfter W, Wierzbicka M, Gawecki W, Popko M, Leszczyńska M, Balcerowiak A. [The reasons of laryngo-tracheal stenosis: a review of literature and analysis of 124 patients]. Otolaryngol Pol. 2009 Jul-Aug;63(4):338-42. doi: 10.1016/S0030-6657(09)70137-4. [Article in Polish].
  46. Tan SL, Neoh CY, Tan HH. Rhinoscleroma: a case series. Singapore Med J. 2012 Feb;53(2):e24-7.
  47. Umphress B, Raparia K. Rhinoscleroma. Arch Pathol Lab Med. 2018 Dec;142(12):1533-6. doi: 10.5858/arpa.2018-0073-RA.
  48. Zafar U, Khan N, Afroz N, Hasan SA. Clinicopathological study of non-neoplastic lesions of nasal cavity and paranasal sinuses. Indian J Pathol Microbiol. 2008 Jan-Mar;51(1):26-9. doi: 10.4103/0377-4929.40386.
  49. Zhong Q, Huang Z, Guo W, Zhang S, Ge W. Rhinoscleroma: Case Report. Am J Otolaryngol. 2010 Sep-Oct;31(5):381-3. doi: 10.1016/j.amjoto.2009.04.006.